Jonathan M Kurie Selected Research

Ipilimumab

1/2021

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan M Kurie Research Topics

Disease

64	Neoplasms (Cancer) 04/2024 - 05/2002
38	Lung Neoplasms (Lung Cancer) 10/2023 - 06/2002
23	Adenocarcinoma of Lung 11/2022 - 09/2002
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 05/2002
21	Neoplasm Metastasis (Metastasis) 10/2023 - 08/2008
15	Carcinogenesis 01/2021 - 02/2002
7	Inflammation (Inflammations) 01/2018 - 08/2002
4	Aneuploidy (Aneuploid) 01/2021 - 01/2018
3	Fibrosis (Cirrhosis) 01/2019 - 01/2018
3	Adenocarcinoma 01/2016 - 04/2006
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2003 - 06/2003
2	Polyploidy 10/2019 - 01/2018
2	Metaplasia 02/2010 - 02/2003
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2009 - 04/2009
2	Carcinoma (Carcinomatosis) 07/2002 - 02/2002
2	Infections 07/2002 - 06/2002
1	Pathologic Complete Response 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2017
1	Osteogenesis Imperfecta (Lobstein Disease) 04/2016

Drug/Important Bio-Agent (IBA)

13	CollagenIBA 10/2023 - 01/2013
11	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2008
9	LigandsIBA 01/2016 - 01/2005
7	Phosphotransferases (Kinase)IBA 01/2021 - 06/2003
6	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 10/2023 - 03/2015
6	HydroxylysineIBA 10/2023 - 03/2015
6	AldehydesIBA 10/2023 - 03/2015
5	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021 - 06/2003
5	MicroRNAs (MicroRNA)IBA 01/2019 - 04/2011
5	ErbB Receptors (EGF Receptor)IBA 08/2008 - 01/2005
4	Zinc Finger E-box-Binding Homeobox 1IBA 11/2022 - 06/2014
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2018
4	Cisplatin (Platino)FDA LinkGeneric 09/2014 - 06/2003
4	RetinoidsIBA 05/2006 - 08/2002
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2015
3	EnzymesIBA 01/2021 - 02/2002
3	CytokinesIBA 10/2017 - 10/2008
3	Conditioned Culture MediaIBA 12/2016 - 01/2012
3	Lysine (L-Lysine)FDA Link 04/2016 - 03/2015
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2008 - 06/2003
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2008 - 06/2003
3	Retinoic Acid Receptor alphaIBA 05/2006 - 08/2002
3	Etoposide (VP 16)FDA LinkGeneric 07/2003 - 06/2003
2	Ubiquitin-Specific ProteasesIBA 12/2022 - 01/2021
2	Small Interfering RNA (siRNA)IBA 12/2022 - 09/2009
2	Collagen Type I (Type I Collagen)IBA 11/2022 - 04/2016
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2020
2	PhosphoproteinsIBA 01/2020 - 01/2017
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2019 - 04/2005
2	matrigelIBA 03/2016 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 02/2002
2	SmokeIBA 01/2014 - 04/2009
2	Cyclin D1IBA 08/2013 - 06/2011
2	Cyclin EIBA 08/2013 - 06/2011
2	Histones (Histone)IBA 08/2013 - 07/2002
2	Peptides (Polypeptides)IBA 11/2012 - 08/2002
2	Mitogen-Activated Protein KinasesIBA 11/2011 - 02/2007
2	TensinsIBA 05/2008 - 02/2008
2	Sirolimus (Rapamycin)FDA Link 07/2007 - 04/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2007 - 06/2003
2	JNK Mitogen-Activated Protein KinasesIBA 05/2006 - 02/2005
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2005 - 07/2002
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2004 - 02/2002
2	Irinotecan (Camptosar)FDA LinkGeneric 07/2003 - 07/2003
2	retinoic acid receptor betaIBA 02/2003 - 07/2002
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	NivolumabIBA 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	UDP glucose-collagen glucosyltransferase (procollagen glucosyltransferase)IBA 01/2021
1	IpilimumabIBA 01/2021
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021
1	CYC065IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2020
1	CFI-402257IBA 10/2019
1	Tyrosine (L-Tyrosine)FDA Link 10/2019
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Propidium (Propidium Iodide)IBA 01/2018
1	2- (3- (4- ((2,6- dimethylmorpholino)methyl)styryl)- 1H- indazol- 6- yl)- 5'- methoxyspiro(cyclopropane- 1,3'- indolin)- 2'- oneIBA 01/2018
1	Competitive Endogenous RNAIBA 01/2018
1	Tacrolimus Binding Proteins (FKBP)IBA 01/2017
1	cyclophilin BIBA 04/2016
1	GelsIBA 03/2016
1	Staphylococcal Protein A (Protein A)IBA 01/2016
1	ClaudinsIBA 01/2016
1	Bone Morphogenetic Protein 4IBA 09/2015
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2015
1	CREB-Binding ProteinIBA 01/2015
1	naphthol AS-TR phosphateIBA 01/2015

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2003
3	Drug Therapy (Chemotherapy) 06/2011 - 06/2003
3	Chemoprevention 02/2010 - 02/2002
1	Immunotherapy 12/2022
1	Transplantation 01/2022
1	Aftercare (After-Treatment) 01/2021